Waters Corp. Stock Outperforms Market On Strong Trading Day

Nanovibronix Inc

Change company Symbol lookup

Select an option...

NAOV Nanovibronix Inc

ETON Eton Pharmaceuticals Inc

LXRX Lexicon Pharmaceuticals Inc

BVS Bioventus Inc

TDS-U Telephone and Data Systems Inc

ELEV Elevation Oncology Inc

FRZA Forza X1 Inc

SIEN Sientra Inc

PMGM Priveterra Acquisition Corp

NVFY Nova LifeStyle Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Value

Company profile

NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus.

Waters Corp. Stock Outperforms Market On Strong Trading Day

5:31 pm ET February 22, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Waters Corp. (WAT) inched 0.28% higher to $321.10 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.16% to 3,991.05 and Dow Jones Industrial Average falling 0.26% to 33,045.09. Waters Corp. closed $47.90 below its 52-week high ($369.00), which the company reached on August 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Thermo Fisher Scientific Inc. (TMO) fell 0.43% to $548.40, Danaher Corp. (DHR) fell 0.27% to $250.11, and General Electric Co. (GE) rose 1.13% to $83.19. Trading volume (427,427) eclipsed its 50-day average volume of 339,783.

Data source: Dow Jones Market Data, FactSet. Data compiled February 22, 2023.

(END) Dow Jones Newswires

February 22, 2023 17:31 ET (22:31 GMT)